Results: VAS use was associated with a 3.76-min reduction in time to reactivity (21.79 vs 25.55, p = 0.011) and a 56% reduction in the need for a biophysical profile (OR: 0.44, 95% CI: 0.21-0.90). Overall, however, we found no significant decrease in time spent on the monitor or in the ATU. Conclusion: Compliance with a strict VAS protocol may improve RG-7388 Apoptosis inhibitor the efficiency of increasingly busy ATUs.”
“BACKGROUND: Hydrocarbon degradation by algal-bacterial systems has advantages over degradation by conventional heterotrophic systems. However, oily wastewaters often contain co-contaminants that may inhibit the

degradation of total petroleum hydrocarbons (TPH), leading to system failure.

RESULTS: This paper reports the effect of phenol on treatment of wastewater containing petroleum hydrocarbons, i.e. diesel oil in a lab-scale rotating

biological contactor with biofilm consisting predominantly of Burkholderia cepacia and a freshwater algal culture. The effect of phenol loading from 0.11-0.69 g phenol m(-2) selleck d(-1) on diesel degradation was studied with 21 h hydraulic retention time and TPH loading of 27.33 g TPH m(-2) d(-1). With increase in phenol loading, complete removal of phenol was observed. However, TPH removal decreased from 99% to 94% and significant decrease in TCOD removal was observed possibly due to biomass growth in suspension. Presence of algal culture in the LY2835219 purchase biofilm made it feasible to operate the RBC at a high organic loading. The benefits included better immobilization of the bacterial culture, release of oxygen and generation of alkalinity. Lowering in pH due to accumulation of acidic intermediates formed during oil biodegradation was not

observed in this study.

CONCLUSION: This system can be recommended for treatment of industrial wastewaters containing TPH and phenols, with proper handling of biosolids. (C) 2010 Society of Chemical Industry”
“Objective: To determine if maternal serum angiogenic factors predict maternal and neonatal complications in women presenting to an acute care setting with suspected preeclampsia. Study design: Maternal serum samples were prospectively collected from women with suspected preeclampsia at the time of initial presentation to hospital triage with signs or symptoms of preeclampsia. Soluble fms-like tyrosine kinase-1 (sFlt1), placental growth factor (PlGF), and soluble endoglin (sEng) were measured by ELISA. The primary outcome was a composite of maternal and neonatal complications. Results: Of 276 women with suspected preeclampsia, 78 developed maternal or neonatal complications. Among women presenting prior to 37 weeks gestation, sFlt1, PlGF, and sEng were significantly different in women who developed maternal and neonatal complications as compared to women without complications.